Vascular Institute Central Switzerland Aarau and Baden, Switzerland.
Department of Systemic Medicine, University of Tor Vergata, Rome, Italy.
Vasa. 2021 Jul;50(4):306-311. doi: 10.1024/0301-1526/a000944. Epub 2021 Feb 22.
: The extent of arterial disease in patients with erectile dysfunction (ED) non-responsive to intracavernosal injection of Alprostadil is of importance for therapeutic options. However, published evidence, in particular angiographically validated is scarce. Here we investigated arterial lesion patterns in this specific patient cohort by selective angiography. : A cohort of 239 patients received a clinical and duplex-sonographic workup for ED of suspected vascular origin. Duplex ultrasound of the cavernosal arteries was performed after intracavernosal injection of 10 μg Alprostadil. Consequently, standardized workup included grading of the erectile and determination of peak systolic velocity (PSV) and end-diastolic velocity (EDV) in both cavernosal arteries. PSV-values below 30 cm/sec indicated reduced arterial flow, whereas EDV-values above 15 cm/sec indicated a venous leak of the pudendal veins. All patients with suspected arterial ED based on duplex sonography underwent contrast-enhanced computed tomography. Endovascular therapy was carried out in ED patients not responsive or with significant side effects to PDE-5-inhibitors or Alprostadil by selective angiographic depiction of erection-related arteries. : 54 patients with a mean age of 61.2 (±9.8) years underwent angioplasty of erectionr elated arteries. Out of these 48/54 (89%) patients presented with an erection considered insufficient for penetration (E0-E3) subsequent to intracavernous application of 10 μg Alprostadil. 14/48 (29%) patients had bilateral arterial obstructions and 34/48 (71%) had unilateral disease. Commonly affected was the internal pudendal artery (n = 31, 65%), followed closely by the common penile artery (n = 30, 64%). The least affected arteries were the dorsal penile (n = 6, 13%), hypogastric (n = 4, 8%), common iliac (n = 4, 8%), cavernosal (n = 4, 8%), and inferior gluteal (n = 1, 2%) arteries. : Arterial obstructions amenable to endovascular revascularization are frequent in patients non-responsive to intracavernosal prostaglandin administration. Therapeutic strategies in ED patients non-responsive to conservative measures should therefore consider endovascular treatment opportunities.
: 勃起功能障碍(ED)患者对前列腺素 E1 海绵体内注射无反应时,动脉疾病的严重程度对治疗选择很重要。然而,目前公布的证据,特别是血管造影验证的证据很少。在此,我们通过选择性血管造影研究了特定患者群体的动脉病变模式。: 239 例患者接受了疑似血管性 ED 的临床和双功能超声检查。在 10μg 前列地尔海绵体内注射后,进行海绵体动脉双功能超声检查。随后,标准化检查包括勃起分级,以及双侧海绵体动脉的收缩期峰值流速(PSV)和舒张末期流速(EDV)的测定。PSV 值低于 30cm/sec 表明动脉血流减少,而 EDV 值高于 15cm/sec 表明阴部静脉有静脉漏。所有基于双功能超声检查怀疑为动脉性 ED 的患者均进行了增强 CT 检查。对疑似动脉性 ED 患者行选择性血管造影显示与勃起相关的动脉,对 PDE-5 抑制剂或前列地尔无反应或有明显不良反应的 ED 患者进行血管内治疗。: 54 例平均年龄 61.2(±9.8)岁的患者进行了与勃起相关的动脉血管成形术。在这些患者中,48/54(89%)患者在 10μg 前列地尔海绵体内注射后出现勃起功能不足(E0-E3),不能进行阴道插入。14/48(29%)例患者双侧动脉阻塞,34/48(71%)例患者单侧动脉阻塞。常见的病变动脉是阴部内动脉(n=31,65%),其次是阴茎总动脉(n=30,64%)。受影响最小的动脉是阴茎背动脉(n=6,13%)、腹下动脉(n=4,8%)、髂总动脉(n=4,8%)、海绵体动脉(n=4,8%)和臀下动脉(n=1,2%)。: 对前列腺素 E1 海绵体内注射无反应的患者中,可进行血管内再血管化的动脉阻塞较为常见。因此,对保守治疗无反应的 ED 患者,治疗策略应考虑血管内治疗机会。